Literature DB >> 10637431

Regulation and activation of p53 and its family members.

M A Lohrum1, K H Vousden.   

Abstract

Regulation of the p53 tumor suppressor protein occurs to a large extent through control of protein stability, and the MDM2 protein has been shown to play a key role in targeting p53 for degradation. Stress signals that activate the p53 response lead to stabilization of p53 through inhibition of MDM2 mediated degradation, and it is becoming evident that a number of mechanisms exist to abrogate this activity of MDM2. Other members of the p53 protein family may also be regulated through protein stability, although MDM2 is not responsible for the degradation of p73. Nevertheless, interactions of p63 and p73 with MDM2 or p53 have been described, suggesting that each of the p53-related proteins can play some role in regulating the activity of the others

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637431     DOI: 10.1038/sj.cdd.4400625

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  25 in total

1.  DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.

Authors:  Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

2.  Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.

Authors:  Reena Rani; Jie Li; Qishen Pang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats.

Authors:  Sohini Walia; Rozy Kamal; D K Dhawan; S S Kanwar
Journal:  Dig Dis Sci       Date:  2018-02-09       Impact factor: 3.199

Review 4.  The MDM2-p53 pathway: multiple roles in kidney development.

Authors:  Samir El-Dahr; Sylvia Hilliard; Karam Aboudehen; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

Review 5.  DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.

Authors:  Ruth A Gjerset
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

6.  Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

Authors:  A Damalas; S Kahan; M Shtutman; A Ben-Ze'ev; M Oren
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 7.  Oxidative stress in Fanconi anemia hematopoiesis and disease progression.

Authors:  Wei Du; Zsuzsanna Adam; Reena Rani; Xiaoling Zhang; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

8.  The energetics of the acetylation switch in p53-mediated transcriptional activation.

Authors:  Kenneth D Eichenbaum; Yoel Rodríguez; Mihaly Mezei; Roman Osman
Journal:  Proteins       Date:  2010-02-01

9.  Nucleophosmin blocks mitochondrial localization of p53 and apoptosis.

Authors:  Sanjit Kumar Dhar; Daret K St Clair
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

10.  Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

Authors:  Víctor Javier Sánchez-Arévalo Lobo; Clara Isabel Aceves Luquero; Luis Alvarez-Vallina; Alex J Tipping; Juan Guinea Viniegra; Javier Hernández Losa; Carlos Parada Cobo; Eva María Galán Moya; Jorge Gayoso Cruz; Junia V Melo; Santiago Ramón y Cajal; Ricardo Sánchez-Prieto
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.